• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对局限性前列腺癌患者的单细胞分析将高格利森评分与免疫抑制特征联系起来。

Single-cell analysis of localized prostate cancer patients links high Gleason score with an immunosuppressive profile.

机构信息

Department of Medicine, Laura & Isaac Perlmutter Cancer Center, NYU Langone Health, New York, New York, USA.

Department of Medicine, Manhattan Campus, VA NY Harbor Health Care System, New York, New York, USA.

出版信息

Prostate. 2023 Jun;83(9):840-849. doi: 10.1002/pros.24524. Epub 2023 Mar 29.

DOI:10.1002/pros.24524
PMID:36988342
Abstract

BACKGROUND

Evading immune surveillance is a hallmark for the development of multiple cancer types. Whether immune evasion contributes to the pathogenesis of high-grade prostate cancer (HGPCa) remains an area of active inquiry.

METHODS

Through single-cell RNA sequencing and multicolor flow cytometry of freshly isolated prostatectomy specimens and matched peripheral blood, we aimed to characterize the tumor immune microenvironment (TME) of localized prostate cancer (PCa), including HGPCa and low-grade prostate cancer (LGPCa).

RESULTS

HGPCa are highly infiltrated by exhausted CD8 T cells, myeloid cells, and regulatory T cells (TRegs). These HGPCa-infiltrating CD8 T cells expressed high levels of exhaustion markers including TIM3, TOX, TCF7, PD-1, CTLA4, TIGIT, and CXCL13. By contrast, a high ratio of activated CD8  effector T cells relative to TRegs and myeloid cells infiltrate the TME of LGPCa. HGPCa CD8  tumor-infiltrating lymphocytes (TILs) expressed more androgen receptor and prostate-specific membran antigen yet less prostate-specific antigen than the LGPCa CD8  TILs. The PCa TME was infiltrated by macrophages but these did not clearly cluster by M1 and M2 markers.

CONCLUSIONS

Our study reveals a suppressive TME with high levels of CD8 T cell exhaustion in localized PCa, a finding enriched in HGPCa relative to LGPCa. These studies suggest a possible link between the clinical-pathologic risk of PCa and the associated TME. Our results have implications for our understanding of the immunologic mechanisms of PCa pathogenesis and the implementation of immunotherapy for localized PCa.

摘要

背景

逃避免疫监视是多种癌症发展的标志。免疫逃避是否有助于高级别前列腺癌(HGPCa)的发病机制仍然是一个活跃的研究领域。

方法

通过对新鲜分离的前列腺切除术标本和匹配的外周血进行单细胞 RNA 测序和多色流式细胞术,我们旨在描述局部前列腺癌(PCa)的肿瘤免疫微环境(TME),包括 HGPCa 和低级别前列腺癌(LGPCa)。

结果

HGPCa 被耗尽的 CD8 T 细胞、髓样细胞和调节性 T 细胞(TRegs)高度浸润。这些 HGPCa 浸润的 CD8 T 细胞表达高水平的衰竭标志物,包括 TIM3、TOX、TCF7、PD-1、CTLA4、TIGIT 和 CXCL13。相比之下,高比例的活化 CD8 效应 T 细胞相对于 TRegs 和髓样细胞浸润 LGPCa 的 TME。HGPCa CD8 肿瘤浸润淋巴细胞(TIL)表达的雄激素受体和前列腺特异性膜抗原多于 LGPCa CD8 TIL,但前列腺特异性抗原较少。PCa TME 浸润巨噬细胞,但这些巨噬细胞没有明显根据 M1 和 M2 标志物聚类。

结论

我们的研究揭示了局部 PCa 中存在高水平 CD8 T 细胞衰竭的抑制性 TME,在 HGPCa 中比 LGPCa 更为丰富。这些研究表明 PCa 的临床病理风险与相关 TME 之间可能存在联系。我们的研究结果对我们理解 PCa 发病机制的免疫机制和实施局部 PCa 的免疫治疗具有重要意义。

相似文献

1
Single-cell analysis of localized prostate cancer patients links high Gleason score with an immunosuppressive profile.对局限性前列腺癌患者的单细胞分析将高格利森评分与免疫抑制特征联系起来。
Prostate. 2023 Jun;83(9):840-849. doi: 10.1002/pros.24524. Epub 2023 Mar 29.
2
Agent Orange as a risk factor for high-grade prostate cancer.橙剂作为高级别前列腺癌的风险因素。
Cancer. 2013 Jul 1;119(13):2399-404. doi: 10.1002/cncr.27941. Epub 2013 May 13.
3
PTEN-deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells.PTEN 缺陷型前列腺癌与免疫抑制性肿瘤微环境相关,这种微环境是由 IDO1 的表达增加和浸润的 FoxP3+T 调节细胞介导的。
Prostate. 2019 Jun;79(9):969-979. doi: 10.1002/pros.23808. Epub 2019 Apr 18.
4
TOX-expressing terminally exhausted tumor-infiltrating CD8 T cells are reinvigorated by co-blockade of PD-1 and TIGIT in bladder cancer.在膀胱癌中,共阻断 PD-1 和 TIGIT 可重新激活表达 TOX 的终末耗竭肿瘤浸润 CD8 T 细胞。
Cancer Lett. 2021 Feb 28;499:137-147. doi: 10.1016/j.canlet.2020.11.035. Epub 2020 Nov 27.
5
Does positive family history of prostate cancer increase the risk of prostate cancer on initial prostate biopsy?直系亲属有前列腺癌病史是否会增加首次前列腺活检时患前列腺癌的风险?
Urology. 2013 Apr;81(4):826-30. doi: 10.1016/j.urology.2012.10.074. Epub 2013 Feb 20.
6
CD226 identifies functional CD8T cells in the tumor microenvironment and predicts a better outcome for human gastric cancer.CD226 可鉴定肿瘤微环境中的功能性 CD8+T 细胞,并预测人类胃癌的更好预后。
Front Immunol. 2023 Mar 28;14:1150803. doi: 10.3389/fimmu.2023.1150803. eCollection 2023.
7
Diffuse large B-cell lymphoma: the significance of CD8 tumor-infiltrating lymphocytes exhaustion mediated by TIM3/Galectin-9 pathway.弥漫性大 B 细胞淋巴瘤:TIM3/Galectin-9 通路介导的 CD8 肿瘤浸润淋巴细胞耗竭的意义。
J Transl Med. 2024 Feb 18;22(1):174. doi: 10.1186/s12967-024-05002-3.
8
Immune cell analyses of the tumor microenvironment in prostate cancer highlight infiltrating regulatory T cells and macrophages as adverse prognostic factors.前列腺癌肿瘤微环境中的免疫细胞分析强调浸润的调节性 T 细胞和巨噬细胞是不良的预后因素。
J Pathol. 2021 Oct;255(2):155-165. doi: 10.1002/path.5757. Epub 2021 Aug 10.
9
Prostate volume predicts high grade prostate cancer both in digital rectal examination negative (ct1c) and positive (≥ct2) patients.前列腺体积在直肠指检阴性(ct1c)和阳性(≥ct2)的患者中均能预测高级别前列腺癌。
Int Braz J Urol. 2014 Sep-Oct;40(5):613-9. doi: 10.1590/S1677-5538.IBJU.2014.05.05.
10
TIGIT and PD1 Co-blockade Restores ex vivo Functions of Human Tumor-Infiltrating CD8 T Cells in Hepatocellular Carcinoma.TIGIT 和 PD1 联合阻断恢复肝癌患者肿瘤浸润 CD8 T 细胞的体外功能。
Cell Mol Gastroenterol Hepatol. 2021;12(2):443-464. doi: 10.1016/j.jcmgh.2021.03.003. Epub 2021 Mar 27.

引用本文的文献

1
The immune landscape of systemic inflammation in prostate cancer.前列腺癌全身炎症的免疫格局。
Cancer Biol Med. 2025 Sep 4;22(8). doi: 10.20892/j.issn.2095-3941.2025.0149.
2
Bolstering CD8 T Cells' Antitumor Immunity: A Promising Strategy to Improve the Response to Advanced Prostate Cancer Treatment.增强CD8 T细胞的抗肿瘤免疫力:一种改善晚期前列腺癌治疗反应的有前景的策略。
Biology (Basel). 2025 May 14;14(5):544. doi: 10.3390/biology14050544.
3
Immunomodulation and Immunotherapy for Patients with Prostate Cancer: An Up-to-Date Review.
前列腺癌患者的免疫调节与免疫治疗:最新综述
Biomedicines. 2025 May 12;13(5):1179. doi: 10.3390/biomedicines13051179.
4
Mechanical signal modulates prostate cancer immune escape by USP8-mediated ubiquitination-dependent degradation of PD-L1 and MHC-1.机械信号通过USP8介导的PD-L1和MHC-1泛素化依赖性降解来调节前列腺癌免疫逃逸。
Cell Death Dis. 2025 May 23;16(1):413. doi: 10.1038/s41419-025-07736-4.
5
Deciphering T-cell exhaustion in the tumor microenvironment: paving the way for innovative solid tumor therapies.解析肿瘤微环境中的T细胞耗竭:为创新实体瘤疗法铺平道路。
Front Immunol. 2025 Apr 1;16:1548234. doi: 10.3389/fimmu.2025.1548234. eCollection 2025.
6
Human single cell RNA-sequencing reveals a targetable CD8 exhausted T cell population that maintains mouse low-grade glioma growth.人类单细胞 RNA 测序揭示了一个可靶向的 CD8 耗竭 T 细胞群体,该群体维持了小鼠低级别神经胶质瘤的生长。
Nat Commun. 2024 Nov 28;15(1):10312. doi: 10.1038/s41467-024-54569-4.
7
Identification of high-risk tumor characteristics in patients with localized prostate cancer using conventional combined with diffusion-weighted MRI imaging parameters.使用传统成像参数结合扩散加权MRI成像参数识别局限性前列腺癌患者的高风险肿瘤特征。
Am J Cancer Res. 2024 Oct 15;14(10):4909-4921. doi: 10.62347/XADT5737. eCollection 2024.
8
Inflammation in Prostate Cancer: Exploring the Promising Role of Phenolic Compounds as an Innovative Therapeutic Approach.前列腺癌中的炎症:探索酚类化合物作为一种创新治疗方法的潜在作用。
Biomedicines. 2023 Nov 24;11(12):3140. doi: 10.3390/biomedicines11123140.
9
Functional and transcriptional heterogeneity within the massively expanding HLADRCD38 CD8 T cell population in acute febrile dengue patients.急性发热登革热患者中 HLADRCD38+CD8 T 细胞群体的功能和转录异质性。
J Virol. 2023 Nov 30;97(11):e0074623. doi: 10.1128/jvi.00746-23. Epub 2023 Oct 19.